Keyword Analysis & Research: neonatal abstinence syndrome monitoring

Keyword Analysis

Keyword Research: People who searched neonatal abstinence syndrome monitoring also searched

Frequently Asked Questions

What is neonatal abstinence syndrome?

Pediatrics (2014) 134 (2): e547–e561. Neonatal abstinence syndrome (NAS) is a result of the sudden discontinuation of fetal exposure to substances that were used or abused by the mother during pregnancy. Withdrawal from licit or illicit substances is becoming more common among neonates in both developed and developing countries.

What is NCBDDD doing to monitor neonatal abstinence syndrome?

NCBDDD is working with the Council of State and Territorial Epidemiologists (CSTE) to apply a consistent surveillance case definition to monitor the number of infants diagnosed with neonatal abstinence syndrome (NAS) at birth. What is NCBDDD Doing to Monitor NAS?

Which states require reporting of “neonatal abstinence syndrome”?

Researchers identified six states with laws that require reporting of “neonatal abstinence syndrome” prior to January 2018. These states include Arizona, Florida, Georgia, Kentucky, Tennessee, and Virginia. These six states require medical providers to report all babies with NAS to their respective state health departments.

Do all in utero opioid exposed neonates develop nasogastric syndrome (NAS)?

While infants exposed to in utero opioids may have withdrawal symptoms, not all will progress to developing NAS. However, all Opioid Exposed Neonates (OENs) require specialized monitoring and care. Unfortunately, the incidence of OENs is increasing in the United States and, more specifically, in Tennessee.

Search Results related to neonatal abstinence syndrome monitoring on Search Engine